Rheumatology
1031 – 1040 of 1579
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Limitations of Antinuclear Antibody Tests (HEp-2) Are Overcome with the Autoimmune Target Test (IT-1) in Systemic Lupus Erythematosus Reply
(
- Contribution to journal › Letter
-
Mark
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor alpha Therapies Does the Risk Change With the Time Since Start of Treatment?
(
- Contribution to journal › Article
-
Mark
Correlation of in-vivo fragmentation of fibromodulin with that generated in-vitro by MMP-13 and ADAMTS-4 but not ADAMTS-5
2009) Annual General Meeting of the British-Society-for-Matrix-Biology In International Journal of Experimental Pathology 90(2). p.99-99(
- Contribution to journal › Published meeting abstract
-
Mark
A comparison between biopsy-proven Lupus and ANCA-associated nephritis within a defined geographical area in southern Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappa B inhibitor that impairs osteoclastogenesis
(
- Contribution to journal › Article
-
Mark
Measures and time points relevant for post-surgical follow-up in patients with inflammatory arthritis: a pilot study
(
- Contribution to journal › Article
-
Mark
Measure for measure. Outcome assessment of arthritis treatment in clinical practice
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cartilage oligomeric matrix protein (COMP) has a dual role in complement regulation
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2829-2829(
- Contribution to journal › Published meeting abstract
-
Mark
C1q inhibits immune complex induced IFN-alpha production in plasmacytoid dendritic cells-A novel link between C1q deficiency and SLE pathogenesis
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2857-2857(
- Contribution to journal › Published meeting abstract
-
Mark
A large multicentre analysis of CTGF - 2945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype
(
- Contribution to journal › Article